SBIR/STTR Research Award
RAPID TEST FOR TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES
Award amount
$104,523Program and phase
STTR · Phase IAward year
2001Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- CC Technology
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (adapted from applicant's abstract): The long-term goal of this
project is to develop a rapid, safe, and sensitive test for the abnormal
isofomms of prion (PrP/res) proteins associated with the transmissible
spongifomm encephalopathies (TSE). The Surface Enhanced Raman Immunoassay
(SERIA) assay to be evaluated will facilitate testing of samples with a minimum
of handling (for safety and speed) at a high level of sensitivity and
specificity. This will allow development of ante mortem tests in addition to
application of the assay to postmortem diagnosis of TSEs. Availably of such
tests will support (a) diagnostic testing of patients potentially affected by
TSEs, (b) rapid screening of animal and possibly human populations for TSEs by
ante mortem (blood, Lymphoid tissues, etc.) or postmortem (Lymphoid tissues,
brain) testing and, (c) studies that seek to better understand the pathogenesis
of TSEs. Chronic Wasting Disease (CWD) of deer and elk will be used as a model
for other TSEs. Specific goals are to evaluate sensitivity of the SERIA for CWD
PrP/res in brain and blood samples and to determine specificity of the SERIA for
CWD PrP/res in brain and blood samples.
PROPOSED COMMERCIAL APPLICATION:
Currently there are no antemortem test for TSE. This will represent the first such test and
will have commercial application for testing patients suspected to have TSE. A much larger
commercial application will be the screening of domestic animals to eliminate TSE.
Technology keywords
Not reported